Omri Amirav-Drory

Omri Amirav-Drory is a Board Member at Nanocarry. Omri has also worked with resistanceBio, Talus Bio, La Jolla Labs, Mana.bio, PANGEA Therapeutics, Pepper Bio, Nanocarry Therapeutics, Gilboa Therapeutics, and NFX in the past.

Omri Amirav-Drory received their Bachelor of Science in Biochemistry and Molecular Biology from Tel Aviv University. Omri then went on to earn their Doctor of Philosophy in Biochemistry from the same school. After completing their Ph.D., they did a postdoctoral fellowship in Biochemistry and Molecular Biology at Stanford University.